SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000927016-02-003360
Filing Date
2002-06-24
Accepted
2002-06-24 16:56:28
Documents
3
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO 1 d10ka.txt 10-K/A 145596
3 CONSENT OF ARTHUR ANDERSEN LLP dex231.txt EX-23.1 611
4 ARTHUR ANDERSEN LETTER dex992.txt EX-99.2 1542
  Complete submission text file 0000927016-02-003360.txt   149584
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-10824 | Film No.: 02685618
SIC: 2835 In Vitro & In Vivo Diagnostic Substances